OMass Therapeutics CEO Ros Deegan on the company's "whole ecosystem" approach to drug discovery

blonca9
May 1, 2024
1 min read

She describes OMass' platform and rare disease focus, and also her thoughts on the UK ecosystem and what it means to participate on the Prime Minister's Business Council.

Recent Posts

See All

On its 10-year anniversary, Arcus Biosciences is taking its 4th molecule into pivotal studies. Co-Founder & CEO Terry Rosen talks HIF-2⍺, TIGIT, and CD73

Siren Biotechnology is using an online platform to raise up to $5 million from the public in a "community round" - it might be a new avenue of funding for biotech companies

Theravance Biopharma has a key pivotal trial readout scheduled for late '25 / early '26 in symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA)

OMass Therapeutics CEO Ros Deegan on the company's "whole ecosystem" approach to drug discovery

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight